VEGFA and breast carcinoma: Thermal gelation of CS in the presence of G carried out to injectable hydrogels for the treatment of breast cancer [203], while mixed polysaccharide hydrogels, including CS-ALG [204] and CS-HA-NIPAAm [205,206] complexes, were designed to produce targeted delivery of anti-VEGF antibody [204], as well as pH-responsive systems for the DOX [205] and DOX@GO [206] vectorization to colon and breast cancer, respectively.